Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Placebo-Controlled, Double-Blind Study to Evaluated the Efficacy and Safety of an Intra-Articular Injection of AMPION in Adults With Pain Due to Osteoarthritis of the Knee

Trial Profile

A Randomized, Placebo-Controlled, Double-Blind Study to Evaluated the Efficacy and Safety of an Intra-Articular Injection of AMPION in Adults With Pain Due to Osteoarthritis of the Knee

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 11 Aug 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs DMI 9523 (Primary)
  • Indications Osteoarthritis
  • Focus Registrational; Therapeutic Use
  • Acronyms PIVOT
  • Sponsors Ampio Pharmaceuticals
  • Most Recent Events

    • 17 Jun 2021 According to an Ampio Pharmaceuticals media release, pooled results from AP-003-A, AP-003-B, and AP-004 trials had been published in Orthopedics 2018.
    • 17 Jun 2021 Pooled results from AP-003-A, AP-003-B, and AP-004 trials presented in an Ampio Pharmaceuticals media release.
    • 22 Nov 2017 Pooled analysis of this and 2 other trials (see CT profiles 214957 and 225451) has been published in Orthopedics, according to an Ampio Pharmaceuticals media release.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top